Method for preparing modified glycosaminoglycans possessing analgesic property

FIELD: organic chemistry, chemical technology.

SUBSTANCE: invention relates to a method for preparing modified glycosaminoglycans possessing analgesic properties. Method involves interaction of glycosaminoglycans with 1-phenyl-2,3-dimethyl-4-aminopyrazolone-5-(4-aminoantipyrine) in aqueous medium at pH = 4.7-4.8 in the presence water-soluble 1-ethyl-3-[3-(dimethlamino)propyl]carbodiimide as a condensing agent at room temperature followed by purification from low-molecular reagents. Method involves a single step that simplifies technology in preparing modified glycosaminoglycans.

EFFECT: improved preparing method.

3 ex

 

The invention relates to the field of chemistry and biochemistry, in particular to a method for producing new substances modified glycosaminoglycans, which can be used in medicine, pharmacology.

Acidic glycosaminoglycans (GAGS) from connective tissues of animals and humans are heteropolysaccharides a linear structure with different molecular weight, degree of sulfation, and include D-glucuronic or L-Euronova acid. The most representative of the class of GAGS are hyaluronic acid (desulfuromonas GAGS), chondroitin sulfates and heparin (most sulfated GAGS).

On the basis of GAG produced the following preparations.

High molecular weight hyaluronic acid (M=106Yes) is part of a viscoelastic gels "Provisk" (Sweden) and "Healon" Canada), used in ophthalmic surgery operations cataract extraction, is the active substance in the films "Seprafilm" to prevent adhesive disease of the peritoneum. Low molecular weight hyaluronic acid impregnated wipes "Gaplus", intended for the treatment of burn disease. Drug "Curiosin" (in the form of a solution or gel) for the treatment of venous ulcers and acne represents Incoloy salt of hyaluronic acid, and the drug Cystistat" is intended to repair a damaged mucosa of the urinary bladder in interstitial cystitis. Hyaluronic acid is a component of cosmetic creams and tonics to stimulate hair growth. Patented the use of hyaluronic acid in the treatment of herpes, psoriasis, and also for the manufacture of suppositories for various purposes.

The chondroitin sulfates from the cartilage of cattle included in the ointment "handaxe" (for local treatment of osteoarthritis), are the active ingredient of drugs "Honored" (for acceleration of reparative processes) and "Romulan" (for treatment of joints).

The known heparin as anticoagulant and antithrombotic agents and is used intravenously for the operations of the vessels. In addition to the anticoagulant and antithrombotic agents, heparin revealed antibacterial, antiviral, anti-inflammatory [Bychkov S.M. New data on heparin. // Questions of medical chemistry. 1981. No. 6. S-735], and antitumor properties [Lapierre F., Holme, K., Lam, L. Chemical modification of heparin that diminish anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. // Glycobiology. 1996. V.6(3). P.355-366]. Also found an inhibitory effect of heparin on the growth and replication of human immunodeficiency virus [C.C. Rider The potential for heparin and its derivatives in therpy and prevention of HIV-1 infection. // Glycoconj. J. 1997. V.14(5). P.639-642]. Heparin ointment, in which, in addition to heparin, is benzocaine (a local anesthetic agent), apply externally with superficial thrombophlebitis and ulcers of the extremities, thrombosis hemorrhoid veins, thus diminishing the inflammatory processes [Mashkovsky PPM Medicines. - Kharkov: Torsing, 1997. 1, 2. - 590 S.].

Covalent binding of low molecular weight biologically active compounds with polymer matrix contributes to reducing drug toxicity, increase the length of their actions, achieves a more effective delivery of drugs to organs-targets. For example, in combination with hyaluronic acid, some of the drug substance form in the epidermis like depo these drugs and are released from the composition slower than in the absence of hyaluronic acid [Vercruysse K.R., G.D. Prestwich // Therapeutic Drug Carrier Systems. 1998. V.15(5). P.513-555].

Known to produce the conjugate of hyaluronic acid (ha-COOH) with ibuprofen, or brovana (d,1-2-(4-isobutylphenyl)-propionic acid), a drug with anti-inflammatory, analgesic and cough activity. Synthesis of conjugates is carried out in three stages:

(1) using 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC) first get conjugates (IIa-b) hyaluronic acid with Digita Itami amber (Ia), adipic (IB) and saburovoi acids (IB) [conversion of carboxyl groups is 30%(IIa), 56 (IIB) and 46 (IIB)];

(2) from ibuprofen and N-hydroxysuccinimide (NHS) in the presence of dicyclohexylcarbodiimide (DCC) synthesize N-hydroxysuccinimidyl ester of ibuprofen (NHS-ester of ibuprofen);

(3) derivatives of hyaluronic acid (IIa-b) in a mixture of 0.1 N. NaHCO3(pH 8.5) and DMF (1:2) react with the NHS-ester of ibuprofen with the formation of conjugates (IIIa-C). Thus it is possible to introduce 24 mol%. ibuprofen (relative to the carboxyl groups of hyaluronic acid).

The authors propose a one-step method for production of modified GAG*(*Hyaluronic acid and a mixture of chondroitin sulfates were obtained from the umbilical cord of newborns, heparin - of pharmacopoeial preparation for intravenous injection.), analgesic properties by interaction of GAG with 1-phenyl-2,3-dimethyl-4-aminopyrazole-5(4-aminoantipyrine) in aqueous medium at pH 4.7-4.8 in the presence of a condensing reagent is a water - soluble 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC). The reaction proceeds at room temperature for 60 minutes with a high conversion of the carboxyl groups of the GAG (83-100%). Cleaning products from low molecular weight reagents is achieved by two - or threefold deposition conjugates ethanol is the alcohol from the aqueous solution.

Spectra1H-NMR were recorded for solutions in D2O spectrometer Bruker AMX-300 (operating frequency for1H-NMR 300.13 MHz), as internal standard used the sodium salt of 3-(trimethylsilyl)-1-propanesulfonic acid. Control the pH of the solutions was performed using a pH meter pH-340".

Water-soluble conjugates GAG from 4-aminoantipyrine was prepared as follows (scheme 2, examples 1-3).

Example 1. To a mixture of 0.15 mmol of hyaluronic acid (from the umbilical cord) and 91.4 mg (0.45 mmol) of 4-aminoantipyrine in 15 ml of N2About add 0.1 N. NaOH (or, if you want, 0.1 N. HCl) to pH 4.7-4.8, then under vigorous stirring and the temperature of 20-22°make 86.4 mg (0.45 mmol) carbodiimide, maintaining pH 4.7-4.8 titration with 0.1 N. HCl. After 1 h to a cooled to 0°the reaction mixture is successively added 0.1 N. NaOH (to pH 7), 2-3 ml of a saturated solution of NaCl and 60-65 ml of chilled ethanol. Dropped the precipitate was separated by centrifugation, dissolved in 10 ml of 6% NaCl, add 30-40 ml of ethanol. Again precipitated precipitate is centrifuged, washed with ethanol (10×3 ml), then ether (10×3 ml) and dried at a temperature of ≤60°and reduced pressure. Get ˜60 mg conjugate of hyaluronic acid with 4-aminoantipyrine, soluble in water. Conversion of carboxyl groups is 83 mol%. (determined from the intensity ratio C the signals of the phenyl protons (δ 7.5 and 7.7 ppm) and the signal metal protons NHCOMe-group (δ 2.1 ppm) in N-acetylglucosaminidase levels of hyaluronic acid).

Example 2. The reaction of chondroitin-4-sulfate and chondroitin-6-sulfate (mixture) with a 4-aminoantipyrine carried out analogously to example 1. Get ˜80 mg of water-soluble product in the form of a white powder. Conversion of carboxyl groups was 87 mol%. (determined from the ratio of intensities of the signals of the phenyl protons (δ 7.5 and 7.7 ppm) and the signal metal protons NHCOMe-group (δ 2.1 ppm) in the levels of N-acetyl-D-glucosamine chondroitin sulfates).

Example 3. The reaction of heparin with 4-aminoantipyrine carried out analogously to example 1. Get ˜90 mg conjugate of heparin, a soluble in water white powder. Conversion of carboxyl groups is 100% mole. (determined from the ratio of intensities of the signals of the phenyl protons (δ 7.5 and 7.7 ppm) and two signals of anomeric protons of heparin in the field of 5.3-5.5 ppm).

Conjugates GAG from 4-aminoantipyrine are structural analogues of antipyrine, analgin, amidopirina, butadiona and have analgesic properties.

Analgesic effect of conjugates was studied on the model of acetic cramps caused by intraperitoneal rat 1 ml ˜1% solution of acetic acid [Trinus FP,Klebanov BM, Mokhort N.A. screening Methods and pharmacological study of anti-inflammatory, analgesic and antipyretic substances (HOWTO). Kiev, 1974. - 27 S.]. Conjugates of hyaluronic acid (1) and chondroitin sulfates (2) with 4-aminoantipyrine was administered at a dose of 50 mg/kg, the conjugate of heparin (3) at the dose of 40 mg/kg as the comparison drug used analgin. Prophylactic administration of the conjugate (1) reduced the frequency of painful manifestations 1.9 times compared to the untreated group of animals, conjugate (2) - 2.7 times, conjugate (3) - 1.6 times. Comparison drug analgin reduced the frequency of painful manifestations in 2.1-2.5 times. Analgesic properties of the conjugate of chondroitin sulfates with 4-aminoantipyrine dose of 50 mg/kg is comparable to aspirin.

A method of obtaining modified glycosaminoglycans, analgesic properties, wherein the glycosaminoglycan is subjected to interaction with 1-phenyl-2,3-dimethyl-4-aminopyrazole-5(4-aminoantipyrine) in aqueous medium at pH 4.7-4.8 in the presence of condensing agent is a water - soluble 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide at room temperature, followed by purification from low molecular weight reagents.



 

Same patents:

FIELD: medicine, food processing industry, in particular production of depolymerized chitosane and products based on the same.

SUBSTANCE: claimed method is based on using of chitosanase in acetic acid medium and spray drying of and depolymerized chitosane and is characterized in that obtained depolymerized chitosane is preliminary converted in non-ionized form by neutralizing of bound acetic acid with ammonium hydroxide followed by precipitation in ethanol and air drying. Further interaction is carried out with ammonium lipoate or glutathione in aqueous medium. Claimed products may be used individually or in combination with other components.

EFFECT: new products for food processing industry and medicine.

4 cl, 2 ex

FIELD: chemical technology.

SUBSTANCE: invention relates to methods for preparing water-soluble saline complexes (associates) of hyaluronic acid with d-metals of IV, V and VI periods of Mendeleyev's periodic system of elements that can be used in pharmacology and cosmetology. Invention describes a method for preparing water-soluble saline complexes of hyaluronic acid involving preparing an aqueous solution of salt of d-metal of IV, V and VI periods of periodic system and its mixing with hyaluronic acid sodium salt, holding the mixture, its stirring, dilution with water and isolation of the end product. For mixing method involves using the amount of aqueous salt of abovementioned d-metal that is equivalent to the amount of carboxy-groups of hyaluronic acid sodium salt or in the limit from 0.95 to 1.10. After dilution with water the solution mixture is subjected for ultrafiltration on separating membranes with simultaneous washing out with aqueous salt solution of abovementioned d-metal firstly and then with deionized water followed by concentrating the product. By another variant for mixing the method involves the amount of aqueous solution of d-metal salt lesser of the equivalent amount of carboxy-groups in hyaluronic acid sodium salt. After dilution with water the mixture is subjected for ultrafiltration on separating membranes with simultaneous washing out with deionized water followed by concentrating the product also. Method is characterized by the decreased time of processes and simplicity.

EFFECT: improved preparing method.

2 cl, 1 tbl

FIELD: natural compounds technology.

SUBSTANCE: chitosan preparation process comprises breaking naturally occurring chitin-containing material, charging it into reactor, demineralization with 6-7% aqueous hydrochloric acid, deproteination with sodium hydroxide solution at 85-95°C, deacetylation with sodium hydroxide solution on heating, decoloration, and washing with water after each stage to pH 6.5. Process is characterized by that chitin-containing material broken to achieve fraction 0.5-6 mm is fed simultaneously into a number of reactors, wherein demineralization is effected with aqueous hydrochloric acid stream at 85-95°C for 1.5 h while controlling pH in each reactor exit to achieve acid concentration in each reactor exit the same as concentration of the initial acid by way of feeding it in a continuous manner. In addition, deproteination is carried out with 6-7% sodium hydroxide solution stream for 1.5 h followed by discharging treated material into autoclave to perform deacetylation simultaneously with decoloration using 50% sodium hydroxide solution at 130-140°C in inert gas environment and in presence of 3-5% hydrogen peroxide solution used in amount 3-5% of the total volume of mixture.

EFFECT: enhanced process efficiency.

1 dwg

Modified chitosan // 2269542

FIELD: organic chemistry of natural compounds, chemical technology, medicine.

SUBSTANCE: invention relates to the group of chitosan-containing compounds. Invention relates to synthesis of modified chitosan of the following structure: wherein n = 150-1400. The modified chitosan possesses the bactericidal activity, in particular, antituberculosis activity.

EFFECT: valuable medicinal properties of modified chitosan.

1 tbl, 1 dwg, 3 ex

FIELD: chemistry and technology of derivatives of polysaccharides, chemical technology.

SUBSTANCE: invention relates to methods for preparing chitosan esters. Invention describes a method for preparing chitosan polyethylene glycol ester that involves dissolving chitosan in acetic acid followed by alkalization. Then the reaction mixture is subjected for effect of ethylene oxide under pressure 1-3 atm and temperature 60-100°C, and the concentration of reaction mass is corrected by addition of distilled water up to the density value of solution 1.030-1.032 g/cm3. Then the reaction mass is purified by electrodialysis at the rate value of solution in treatment chambers 3.0 cm/s, not less, temperature 20-45°C, the current density value 0.25-0.75 A/dm2 and the constant volume of the reaction mass. Method provides enhancing the effectiveness of purification by electrodialysis due to reducing energy consumptions. Chitosan esters can be used in medicine, cosmetics, food and chemical industry.

EFFECT: improved preparing method.

5 ex

FIELD: chemical technology of natural compounds.

SUBSTANCE: invention describes a method for preparing water-soluble derivatives of chitosan. Method involves treatment of chitosan with acid medium up to its swelling wherein vapor medium water-acid is used as acid medium. Treatment of chitosan is carried out with vapor of monobasic acid aqueous solution taken among the group including hydrochloric acid, formic acid and acetic acid. Method allows simplifying technology in preparing water-soluble derivatives of chitosan.

EFFECT: improved preparing method.

4 cl, 1 tbl, 9 ex

FIELD: organic chemistry.

SUBSTANCE: claimed method includes subsequent chitosane-containing raw material with non-polar liquefied gas, water, alkali, water, acid, water, alkali, and water to produce target product in form of solid residue, wherein in at least first extraction step pressure in reaction mixture is periodically released to provide extractant boiling, and than increased up to starting value.

EFFECT: method with reduced energy consumption.

FIELD: fish industry.

SUBSTANCE: method involves providing deacetylation of raw material with the use of preliminarily cooled alkaline solution; washing and drying. Deacetylation process is performed in three stages, first stage being performed for 7 days and subsequent two stages being performed for 2 hours each, combined with thermal processing at temperature of 55-590C. Washing process is provided after each deacetylation stage.

EFFECT: provision for producing of chitosan from chitin of cancerous with increased extent of deacetylation, while native properties of natural polymer being kept, without breaking of glycoside binding chain.

3 ex

The invention relates to macroporous chitosan granules having a relatively large and uniform pore size of 30-150 μm inside and outside, which are distributed from the surface to the area of the nucleus, and the way they are received, which includes the following stages: adding dropwise chitosan solution, the aqueous chitosan solution, or a mixture thereof in the low-temperature organic solvent or liquid nitrogen; regulation of pore size using the method of phase separation due to temperature differences
The invention relates to a method for producing derivatives of chitosan oligosaccharide and can be used in medical and food industries, as components of various compositions

FIELD: bioorganic chemistry, chemical technology.

SUBSTANCE: invention describes N-deacylated N-sulfatized derivative of polysaccharide K5 epimerized up to at least to 40% of the content of L-iduronic acid with respect to the total content of uronic acids and with molecular mass 2000-30000 Da and comprising 25-50% by the chain weight showing the high affinity to ATIII and possessing anti-coagulant and anti-thrombosis activity with the ratio of abovementioned activities of HCII/antiXa from 1.5 to 4. Also, invention describes a method for preparing a derivative of polysaccharide K5 comprising isolation of polysaccharide K5 from Escherichia coli cells, N-deacylation and N-sulfatization, C-5-epimerization of D-glucuronic acid to L-induronic acid, supersulfatization, selective O-desulfatization, selective 6-O-sulfatization and N-sulfatization. The reaction of C-5-epimerization is carried out by using the enzyme glucuronosyl-C-5 epimerase in the soluble or immobilized form in the presence of bivalent cations chosen from the group comprising Ba, Ca, Mg and Mn.

EFFECT: improved preparing method, valuable medicinal properties of substances.

12 cl, 3 tbl, 12 dwg, 12 ex

FIELD: bioorganic chemistry, chemical technology.

SUBSTANCE: invention describes N-deacylated N-sulfatized derivative of polysaccharide K5 epimerized up to at least to 40% of the content of L-iduronic acid with respect to the total content of uronic acids and with molecular mass 2000-30000 Da and comprising 25-50% by the chain weight showing the high affinity to ATIII and possessing anti-coagulant and anti-thrombosis activity with the ratio of abovementioned activities of HCII/antiXa from 1.5 to 4. Also, invention describes a method for preparing a derivative of polysaccharide K5 comprising isolation of polysaccharide K5 from Escherichia coli cells, N-deacylation and N-sulfatization, C-5-epimerization of D-glucuronic acid to L-induronic acid, supersulfatization, selective O-desulfatization, selective 6-O-sulfatization and N-sulfatization. The reaction of C-5-epimerization is carried out by using the enzyme glucuronosyl-C-5 epimerase in the soluble or immobilized form in the presence of bivalent cations chosen from the group comprising Ba, Ca, Mg and Mn.

EFFECT: improved preparing method, valuable medicinal properties of substances.

12 cl, 3 tbl, 12 dwg, 12 ex

FIELD: pectin production.

SUBSTANCE: claimed method includes swelling of plant raw materials, hydrolysis, and extraction by using of polyharmonic vibration of 15-50 Hz frequency, wherein swelling and hydrolysis are carried out in one step with hydrochloric acid solution followed by separation of solid and liquid phases and recycling of the last in swelling and hydrolysis step. Separated solid phase is diluted with water and used for extraction of pectin substances under vibration action. Further obtained extract is concentrated and purified in ultrafiltration apparatus to obtain pectin concentrate followed by dying thereof in vacuum drier.

EFFECT: accelerated method for pectin production; reduced reagent consumption.

2 ex, 2 tbl

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention describes a water-soluble sodium-, calcium-, iron-polygalactouronate of the general formula (I): used as a stimulating agent of the hemopoiesis process. The compound is prepared by treatment of pectin with alkali NaOH solution at temperature 50-60°C and successive addition of aqueous solution of calcium and iron salts followed by precipitation with alcohol, centrifugation and drying. The compound can be used in using both a solid substance and as solutions for pharmaceutical aims.

EFFECT: valuable medicinal properties of agent.

3 cl, 2 tbl, 4 ex

FIELD: medicine, food processing industry, in particular production of depolymerized chitosane and products based on the same.

SUBSTANCE: claimed method is based on using of chitosanase in acetic acid medium and spray drying of and depolymerized chitosane and is characterized in that obtained depolymerized chitosane is preliminary converted in non-ionized form by neutralizing of bound acetic acid with ammonium hydroxide followed by precipitation in ethanol and air drying. Further interaction is carried out with ammonium lipoate or glutathione in aqueous medium. Claimed products may be used individually or in combination with other components.

EFFECT: new products for food processing industry and medicine.

4 cl, 2 ex

FIELD: food processing industry, in particular production of inulin-containing solution from earth apple.

SUBSTANCE: claimed method includes earth apple is washed, sliced and dried up to humidity of 6-10 %. Obtained product is milled, meal is extracted with water at 80-85°C for 1.0-1.5 h to obtain water soluble fructosanes. Inulin-containing solution is separated from fiber, lightened with activated lightening carbon mixed with perlite and purified by nanofiltration using semipermeable membrane hawing holdback limit of 4000 Da or more.

EFFECT: effective perrenial method for production of inulin-containing solution from earth apple harvested in autumn.

4 ex

FIELD: food processing industry, in particular production of inulin-containing solution from earth apple.

SUBSTANCE: claimed method includes earth apple is washed, sliced and dried up to humidity of 6-10 %. Obtained product is milled, meal is extracted with water at 80-85°C for 1.0-1.5 h to obtain water soluble fructosanes. Inulin-containing solution is separated from fiber, lightened with activated lightening carbon mixed with perlite and purified by nanofiltration using semipermeable membrane hawing holdback limit of 4000 Da or more.

EFFECT: effective perrenial method for production of inulin-containing solution from earth apple harvested in autumn.

4 ex

FIELD: organic chemistry, drugs.

SUBSTANCE: invention relates to complex of general formula (X)n-Y, wherein X are identical or different and represent folic acid, folinic acid, dihydrofolic acid, tetrahydrofolic acid, tetrahyldopterine, pteroyl-polyglutamic acid, 2-deaminohydroxyfolic acid, 1-denitrofolic acid, 3-denitrofolic acid, 8-denitrofolic acid; Y represents polysaccharide different from arabinogalactane, selected from group containing glucanes, dextranes, polysaccharoses, fructosanes, heteropolysaccharides, homo- or heteropolysaccharide sulfates, ginseng pectin polysaccharide and other pectin polysaccharides, gumghatti, alginate, etc; or Y is selected from polyethylene oxide, methoxypolyethylene glycol and hydrophilic alcohol polymers; n >=1. Said complex permeates into in cell via pathway involving folic acid receptor on cell membrane. Complex of present invention is useful in production of pharmaceutical agents having antitumor activity.

EFFECT: new intermediates for antitumor agent production.

10 cl, 7 ex, 11 dwg, 2 tbl

FIELD: organic chemistry, drugs.

SUBSTANCE: invention relates to complex of general formula (X)n-Y, wherein X are identical or different and represent folic acid, folinic acid, dihydrofolic acid, tetrahydrofolic acid, tetrahyldopterine, pteroyl-polyglutamic acid, 2-deaminohydroxyfolic acid, 1-denitrofolic acid, 3-denitrofolic acid, 8-denitrofolic acid; Y represents polysaccharide different from arabinogalactane, selected from group containing glucanes, dextranes, polysaccharoses, fructosanes, heteropolysaccharides, homo- or heteropolysaccharide sulfates, ginseng pectin polysaccharide and other pectin polysaccharides, gumghatti, alginate, etc; or Y is selected from polyethylene oxide, methoxypolyethylene glycol and hydrophilic alcohol polymers; n >=1. Said complex permeates into in cell via pathway involving folic acid receptor on cell membrane. Complex of present invention is useful in production of pharmaceutical agents having antitumor activity.

EFFECT: new intermediates for antitumor agent production.

10 cl, 7 ex, 11 dwg, 2 tbl

FIELD: chemical technology.

SUBSTANCE: invention relates to methods for preparing water-soluble saline complexes (associates) of hyaluronic acid with d-metals of IV, V and VI periods of Mendeleyev's periodic system of elements that can be used in pharmacology and cosmetology. Invention describes a method for preparing water-soluble saline complexes of hyaluronic acid involving preparing an aqueous solution of salt of d-metal of IV, V and VI periods of periodic system and its mixing with hyaluronic acid sodium salt, holding the mixture, its stirring, dilution with water and isolation of the end product. For mixing method involves using the amount of aqueous salt of abovementioned d-metal that is equivalent to the amount of carboxy-groups of hyaluronic acid sodium salt or in the limit from 0.95 to 1.10. After dilution with water the solution mixture is subjected for ultrafiltration on separating membranes with simultaneous washing out with aqueous salt solution of abovementioned d-metal firstly and then with deionized water followed by concentrating the product. By another variant for mixing the method involves the amount of aqueous solution of d-metal salt lesser of the equivalent amount of carboxy-groups in hyaluronic acid sodium salt. After dilution with water the mixture is subjected for ultrafiltration on separating membranes with simultaneous washing out with deionized water followed by concentrating the product also. Method is characterized by the decreased time of processes and simplicity.

EFFECT: improved preparing method.

2 cl, 1 tbl

FIELD: biotechnology.

SUBSTANCE: invention relates to inhibitor of matrix metalloproteinases representing extract from fungus Canoderma atrum obtained by using of water and/or lower alcohols as extractant. Also disclosed are pharmaceutical agent for inhibition of tumor metastasis containing of 0.03-10 wt.% of abovementioned extract and foodstuff containing claimed extract.

EFFECT: improved inhibitor of matrix proteinases.

3 cl, 18 ex, 4 tbl

Up!